$INFN
Infinera Corp Stock $infn

$infn Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000119312513318863 Filed on August 05, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$138.4M	$93.46M
YoY Change	48.07%	-2.6%
Cost Of Revenue	$86.73M	$61.08M
YoY Change	41.99%	4.34%
Gross Profit	$51.65M	$32.37M
YoY Change	59.55%	-13.47%
Gross Profit Margin	37.33%	34.64%
Selling, General & Admin	$28.58M	$30.10M
YoY Change	-5.04%	5.23%
% of Gross Profit	55.33%	92.97%
Research & Development	$31.68M	$31.68M
YoY Change	0.02%	-3.72%
% of Gross Profit	61.33%	97.84%
Depreciation & Amortization	$6.300M	$5.700M
YoY Change	10.53%	35.71%
% of Gross Profit	12.2%	17.61%
Operating Expenses	$60.26M	$61.77M
YoY Change	-2.45%	0.46%
Operating Profit	-$8.608M	-$29.40M
YoY Change	-70.72%	22.1%
Interest Expense	$849.0K	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	-$800.0K	$377.0K
YoY Change	-312.2%	53.88%
Pretax Income	-$9.408M	-$29.02M
YoY Change	-67.58%	21.78%
Income Tax	$601.0K	$527.0K
% Of Pretax Income
Net Earnings	-$10.01M	-$29.55M
YoY Change	-66.13%	22.13%
Net Earnings / Revenue	-7.23%	-31.62%
Basic Earnings Per Share	-$0.09	-$0.27
Diluted Earnings Per Share	-$0.09	-$0.27
COMMON SHARES
Basic Shares Outstanding	116.9M shares	110.4M shares
Diluted Shares Outstanding	116.9M shares	110.4M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$301.6M	$190.0M
YoY Change	58.74%	-29.26%
Cash & Equivalents	$181.2M	$84.99M
Short-Term Investments	$120.4M	$105.0M
Other Short-Term Assets	$15.40M	$13.10M
YoY Change	17.56%	-38.21%
Inventory	$121.3M	$115.1M
Prepaid Expenses
Receivables	$96.67M	$56.20M
Other Receivables	$1.112M	$1.500M
Total Short-Term Assets	$536.1M	$375.9M
YoY Change	42.62%	-13.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$78.39M	$82.40M
YoY Change	-4.87%	41.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$32.40M	$26.10M
YoY Change	24.14%	110.48%
Other Assets	$5.564M	$6.400M
YoY Change	-13.06%	-67.51%
Total Long-Term Assets	$120.3M	$114.9M
YoY Change	4.67%	27.1%
TOTAL ASSETS
Total Short-Term Assets	$536.1M	$375.9M
Total Long-Term Assets	$120.3M	$114.9M
Total Assets	$656.4M	$490.8M
YoY Change	33.73%	-6.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$35.98M	$37.70M
YoY Change	-4.57%	31.82%
Accrued Expenses	$18.22M	$40.00M
YoY Change	-54.45%	-8.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$119.0M	$99.90M
YoY Change	19.08%	-4.68%
LONG-TERM LIABILITIES
Long-Term Debt	$105.6M	$0.00
YoY Change
Other Long-Term Liabilities	$18.34M	$25.50M
YoY Change	-28.07%	28.79%
Total Long-Term Liabilities	$123.9M	$25.50M
YoY Change	385.96%	28.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$119.0M	$99.90M
Total Long-Term Liabilities	$123.9M	$25.50M
Total Liabilities	$242.9M	$125.4M
YoY Change	93.68%	0.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$597.7M
YoY Change
Common Stock	$1.000B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$399.2M	$365.3M
YoY Change
Total Liabilities & Shareholders Equity	$656.4M	$490.8M
YoY Change	33.73%	-6.5%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$10.01M	-$29.55M
YoY Change	-66.13%	22.13%
Depreciation, Depletion And Amortization	$6.300M	$5.700M
YoY Change	10.53%	35.71%
Cash From Operating Activities	$17.90M	-$22.70M
YoY Change	-178.85%	22600.0%
INVESTING ACTIVITIES
Capital Expenditures	-$4.500M	-$6.200M
YoY Change	-27.42%	-7.46%
Acquisitions
YoY Change
Other Investing Activities	-$82.00M	$17.40M
YoY Change	-571.26%	-680.0%
Cash From Investing Activities	-$86.60M	$11.40M
YoY Change	-859.65%	-216.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	151.4M	100.0K
YoY Change	151300.0%	-120.0%
NET CHANGE
Cash From Operating Activities	17.90M	-22.70M
Cash From Investing Activities	-86.60M	11.40M
Cash From Financing Activities	151.4M	100.0K
Net Change In Cash	82.70M	-11.20M
YoY Change	-838.39%	7.69%
FREE CASH FLOW
Cash From Operating Activities	$17.90M	-$22.70M
Capital Expenditures	-$4.500M	-$6.200M
Free Cash Flow	$22.40M	-$16.50M
YoY Change	-235.76%	-350.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	118068260	shares
CY2012Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	12986000
CY2013Q2	infn	Closing Price Of Common Stock ClosingPriceOfCommonStock	10.67
CY2012Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	13702000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84988000
CY2012Q2	infn	Anti Dilutive Shares Excluded From Computation Of Diluted Net Earnings Loss Per Share AntiDilutiveSharesExcludedFromComputationOfDilutedNetEarningsLossPerShare	18880000	shares
CY2013Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	16672000
CY2013Q1	infn	Available For Sale Auction Rate Securities Called At Par Value AvailableForSaleAuctionRateSecuritiesCalledAtParValue	100000
CY2013Q1	infn	Available For Sale Auction Rate Securities Tender Value AvailableForSaleAuctionRateSecuritiesTenderValue	3000000
CY2013Q1	infn	Disposal Of Auction Rate Securities Par Value DisposalOfAuctionRateSecuritiesParValue	3100000
CY2013Q1	infn	Available For Sale Auction Rate Securities Tender Value As Percent Of Par Value AvailableForSaleAuctionRateSecuritiesTenderValueAsPercentOfParValue	0.95	pure
CY2013Q1	infn	Number Of Shares To Be Purchased On Exercise Of Warrants NumberOfSharesToBePurchasedOnExerciseOfWarrants	92592	shares
CY2013Q2	invest	Derivative Notional Amount DerivativeNotionalAmount	23974000
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117947000	shares
CY2013Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0175	pure
CY2013Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	12.58
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117947000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0512	pure
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.25
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7396000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	17200000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	500000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	7.18
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	7381000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6811000	shares
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18221000
CY2013Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	11369000
CY2013Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	105580000
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	128705000
CY2013Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7623000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	35977000
CY2013Q2	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	0
CY2013Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	8332000
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	118956000
CY2013Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	3600000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3420000
CY2013Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	19701000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	399150000
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24997000
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18341000
CY2013Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	84000
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1000106000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	133000
CY2013Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1150000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-597654000
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31429000
CY2013Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1707000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	118000
CY2013Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	166800000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	656360000
CY2013Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2964000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Long Term Investments LongTermInvestments	23427000
CY2013Q2	us-gaap	Assets Current AssetsCurrent	536090000
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	276421000
CY2013Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1112000
CY2013Q2	us-gaap	Cost Method Investments CostMethodInvestments	9000000
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3850000
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5564000
CY2013Q2	us-gaap	Deferred Costs DeferredCosts	38000
CY2013Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	41048000
CY2013Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	0
CY2013Q2	us-gaap	Assets Assets	656360000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	26211000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	181211000
CY2013Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	9792000
CY2013Q2	us-gaap	Short Term Investments ShortTermInvestments	120437000
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	96668000
CY2013Q2	us-gaap	Inventory Net InventoryNet	121317000
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	207096000
CY2013Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	276329000
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14495000
CY2013Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	850000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26252000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	24647000
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2094000
CY2013Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	70477000
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	78391000
CY2013Q2	infn	Customer Proposal Guarantee CustomerProposalGuarantee	1400000
CY2013Q2	infn	Anti Dilutive Shares Excluded From Computation Of Diluted Net Earnings Loss Per Share AntiDilutiveSharesExcludedFromComputationOfDilutedNetEarningsLossPerShare	15080000	shares
CY2013Q2	infn	Value Added Tax License ValueAddedTaxLicense	1500000
CY2013Q2	infn	Available For Sale Auction Rate Securities Tender Value As Percent Of Par Value AvailableForSaleAuctionRateSecuritiesTenderValueAsPercentOfParValue	0.95	pure
CY2013Q2	infn	Loss Contingency Related To Non Cancelable Purchase Commitments LossContingencyRelatedToNonCancelablePurchaseCommitments	5525000
CY2013Q2	infn	Provision Made For Plaintiff In Lawsuit ProvisionMadeForPlaintiffInLawsuit	0
CY2013Q2	infn	Accrued Rebate And Customer Prepay Liability Current AccruedRebateAndCustomerPrepayLiabilityCurrent	611000
CY2013Q2	infn	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	116000
CY2013Q2	infn	Property Leases PropertyLeases	700000
CY2013Q2	infn	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	24000
CY2011Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	12865000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94458000
CY2012Q4	invest	Derivative Notional Amount DerivativeNotionalAmount	24377000
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	112461000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112461000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.13
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9008000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25483000
CY2012Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	9220000
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	117226000
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9991000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	61428000
CY2012Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	805000
CY2012Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	7262000
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	144047000
CY2012Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	3600000
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2228000
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	16482000
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22325000
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15557000
CY2012Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	112000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	356136000
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	930618000
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	94000
CY2012Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1516000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-572366000
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	26744000
CY2012Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3588000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	112000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	528170000
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3210000
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Long Term Investments LongTermInvestments	2874000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	429497000
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	117741000
CY2012Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2909000
CY2012Q4	us-gaap	Cost Method Investments CostMethodInvestments	9000000
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3868000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1683000
CY2012Q4	us-gaap	Deferred Costs DeferredCosts	100000
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	57281000
CY2012Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	805000
CY2012Q4	us-gaap	Assets Assets	528170000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104666000
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	13003000
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	76146000
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	107039000
CY2012Q4	us-gaap	Inventory Net InventoryNet	127809000
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	197569000
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	117923000
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9899000
CY2012Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	1029000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5726000
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	57525000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	80343000
CY2012Q4	infn	Customer Proposal Guarantee CustomerProposalGuarantee	1400000
CY2012Q4	infn	Value Added Tax License ValueAddedTaxLicense	1500000
CY2012Q4	infn	Loss Contingency Related To Non Cancelable Purchase Commitments LossContingencyRelatedToNonCancelablePurchaseCommitments	5401000
CY2012Q4	infn	Property Leases PropertyLeases	700000
CY2012Q4	infn	Accrued Rebate And Customer Prepay Liability Current AccruedRebateAndCustomerPrepayLiabilityCurrent	1284000
CY2012Q4	infn	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	11000
CY2012Q4	infn	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	193000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.46
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109534000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.46
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-28501000
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	837000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109534000	shares
	us-gaap	Revenues Revenues	198159000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1533000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-50530000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-3910000
	us-gaap	Gross Profit GrossProfit	72801000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	477000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-49055000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	42853000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	170234000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-275000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	595000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	503000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-200000
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	120000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	501000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-49283000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	26871000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-263000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24416000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	228000
	us-gaap	Net Income Loss NetIncomeLoss	-50161000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1098000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24770000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-369000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	839000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19770000
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	230000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	60000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23404000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6254000
	us-gaap	Cost Of Services CostOfServices	9660000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	115341000
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4952000
	us-gaap	Share Based Compensation ShareBasedCompensation	20367000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11224000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9470000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	36019000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5194000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2272000
	us-gaap	Interest Expense InterestExpense	0
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8753000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7093000
	us-gaap	Cost Of Revenue CostOfRevenue	125358000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12855000
	us-gaap	Product Warranty Expense ProductWarrantyExpense	5824000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	62661000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20367000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	75700000
	us-gaap	Operating Expenses OperatingExpenses	122084000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1106000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-78000
	infn	Provision For Income Taxes Percentage ProvisionForIncomeTaxesPercentage	0.023	pure
	infn	Realized Gains On Calls RealizedGainsOnCalls	500000
	infn	Product Warranty Utilization ProductWarrantyUtilization	3804000
	infn	Reimbursement Of Manufacturing Capacity Advance ReimbursementOfManufacturingCapacityAdvance	50000
	infn	Ratable Product And Related Support And Services RatableProductAndRelatedSupportAndServices	1054000
	infn	Provision For Recovery Of Other Receivables ProvisionForRecoveryOfOtherReceivables	0
	infn	Transfer Of Inventory To Fixed Assets TransferOfInventoryToFixedAssets	0
	infn	Allocated Share Based Compensation Expense Before Amortization Of Prior Periods Deferred Inventory Cost AllocatedShareBasedCompensationExpenseBeforeAmortizationOfPriorPeriodsDeferredInventoryCost	18198000
	infn	Proceeds From Maturities And Calls Of Investments ProceedsFromMaturitiesAndCallsOfInvestments	70464000
	infn	Product Warranty Change In Estimate ProductWarrantyChangeInEstimate	-1183000
	infn	Amortization Of Deferred Inventory Cost Recognized As Share Based Compensation Expense AmortizationOfDeferredInventoryCostRecognizedAsShareBasedCompensationExpense	2169000
	infn	Cost Of Ratable Product And Related Support And Services CostOfRatableProductAndRelatedSupportAndServices	357000
	infn	Non Cash Settlement For Manufacturing Capacity Advance NonCashSettlementForManufacturingCapacityAdvance	275000
	infn	Other Comprehensive Income Loss Reclassification Adjustment For Available For Sale Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAvailableForSaleSecuritiesIncludedInNetIncomeNetOfTax	-286000
	dei	Trading Symbol TradingSymbol	INFN
	dei	Entity Registrant Name EntityRegistrantName	INFINERA CORP
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-29
	dei	Entity Central Index Key EntityCentralIndexKey	0001138639
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115609000	shares
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	79.4834	pure
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.95
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y1M6D
	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days DebtInstrumentConvertibleThresholdConsecutiveTradingDays	P30D
	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	1000
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.22
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3375000
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-108000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	243000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.15
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	3219000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	115609000	shares
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.30	pure
	us-gaap	Operating Income Loss OperatingIncomeLoss	-23550000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1195000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	417000	shares
	us-gaap	Revenues Revenues	263010000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4083000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26480000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-216000
	us-gaap	Gross Profit GrossProfit	94356000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1629000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24356000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	130828000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	227962000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-361000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1148000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	404000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-200000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	34020000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-918000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10332000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-806000
	us-gaap	Net Income Loss NetIncomeLoss	-25288000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-450000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-791000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1192000
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1026000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1499000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9431000
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	6000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21298000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	630000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	155466000
	us-gaap	Cost Of Services CostOfServices	13009000
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	166000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	155481000
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4440000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3932000
	us-gaap	Share Based Compensation ShareBasedCompensation	16159000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	40000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12621000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	76545000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	35201000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2850000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-220000
	us-gaap	Interest Expense InterestExpense	849000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-23980000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12496000
	us-gaap	Cost Of Revenue CostOfRevenue	168654000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-74768000
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1605000
	us-gaap	Product Warranty Expense ProductWarrantyExpense	10346000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61407000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	50000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	144469000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16159000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	65500000
	us-gaap	Interest Expense Debt InterestExpenseDebt	849000
	us-gaap	Operating Expenses OperatingExpenses	117906000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	580000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	932000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-778000
	infn	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue	0
	infn	Provision For Income Taxes Percentage ProvisionForIncomeTaxesPercentage	0.038	pure
	infn	Realized Gains On Calls RealizedGainsOnCalls	200000
	infn	Product Warranty Utilization ProductWarrantyUtilization	4138000
	infn	Reimbursement Of Manufacturing Capacity Advance ReimbursementOfManufacturingCapacityAdvance	0
	infn	Ratable Product And Related Support And Services RatableProductAndRelatedSupportAndServices	1028000
	infn	Provision For Recovery Of Other Receivables ProvisionForRecoveryOfOtherReceivables	-88000
	infn	Transfer Of Inventory To Fixed Assets TransferOfInventoryToFixedAssets	4684000
	infn	Allocated Share Based Compensation Expense Before Amortization Of Prior Periods Deferred Inventory Cost AllocatedShareBasedCompensationExpenseBeforeAmortizationOfPriorPeriodsDeferredInventoryCost	12867000
	infn	Proceeds From Maturities And Calls Of Investments ProceedsFromMaturitiesAndCallsOfInvestments	62647000
	infn	Debt Instrument Repurchase Price As Percentage Of Principal Amount Plus Accrued And Unpaid Interest In Event Of Change DebtInstrumentRepurchasePriceAsPercentageOfPrincipalAmountPlusAccruedAndUnpaidInterestInEventOfChange	1.00	pure
	infn	Product Warranty Change In Estimate ProductWarrantyChangeInEstimate	-2989000
	infn	Contractual Interest Expense ContractualInterestExpense	219000
	infn	Amortization Of Deferred Inventory Cost Recognized As Share Based Compensation Expense AmortizationOfDeferredInventoryCostRecognizedAsShareBasedCompensationExpense	3292000
	infn	Available For Sale Investment Maturity Term Maximum AvailableForSaleInvestmentMaturityTermMaximum	P17M
	infn	Cost Of Ratable Product And Related Support And Services CostOfRatableProductAndRelatedSupportAndServices	164000
	infn	Non Cash Settlement For Manufacturing Capacity Advance NonCashSettlementForManufacturingCapacityAdvance	0
	infn	Cost Method Investments Ownership Percent Range Ceiling CostMethodInvestmentsOwnershipPercentRangeCeiling	0.20	pure
	infn	Euro Denominated Receivables And Typically Maturities EuroDenominatedReceivablesAndTypicallyMaturities	no more than 30 days
	infn	Number Of Shares Available For Grant Cost NumberOfSharesAvailableForGrantCost	2900000	shares
	infn	Other Comprehensive Income Loss Reclassification Adjustment For Available For Sale Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAvailableForSaleSecuritiesIncludedInNetIncomeNetOfTax	-166000
	infn	Range Of Shares Issued Upon Restated Stock Option And Incentive Plan RangeOfSharesIssuedUponRestatedStockOptionAndIncentivePlan	0.5
	infn	Debt Instrument Convertible Threshold Maximum Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdMaximumPercentageOfStockPriceTrigger	0.98	pure
	infn	Debt Instruments Convertible Threshold Trading Days DebtInstrumentsConvertibleThresholdTradingDays	P20D
CY2012	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	3703000
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110403000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.27
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110403000	shares
CY2012Q2	us-gaap	Revenues Revenues	93458000
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30389000
CY2012Q2	us-gaap	Gross Profit GrossProfit	32374000
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29022000
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	77843000
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	149000
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	228000
CY2012Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	600000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-17000
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29399000
CY2012Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	15092000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-645000
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	377000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-29549000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-840000
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	45000
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12320000
CY2012Q2	us-gaap	Cost Of Services CostOfServices	4901000
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	56017000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-60000
CY2012Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17777000
CY2012Q2	us-gaap	Interest Expense InterestExpense	0
CY2012Q2	us-gaap	Cost Of Revenue CostOfRevenue	61084000
CY2012Q2	us-gaap	Product Warranty Expense ProductWarrantyExpense	3103000
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31676000
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10930000
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	61773000
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	527000
CY2012Q2	infn	Provision For Income Taxes Percentage ProvisionForIncomeTaxesPercentage	0.018	pure
CY2012Q2	infn	Realized Gains On Calls RealizedGainsOnCalls	500000
CY2012Q2	infn	Product Warranty Utilization ProductWarrantyUtilization	1831000
CY2012Q2	infn	Ratable Product And Related Support And Services RatableProductAndRelatedSupportAndServices	523000
CY2012Q2	infn	Allocated Share Based Compensation Expense Before Amortization Of Prior Periods Deferred Inventory Cost AllocatedShareBasedCompensationExpenseBeforeAmortizationOfPriorPeriodsDeferredInventoryCost	9830000
CY2012Q2	infn	Product Warranty Change In Estimate ProductWarrantyChangeInEstimate	-556000
CY2012Q2	infn	Amortization Of Deferred Inventory Cost Recognized As Share Based Compensation Expense AmortizationOfDeferredInventoryCostRecognizedAsShareBasedCompensationExpense	1100000
CY2012Q2	infn	Cost Of Ratable Product And Related Support And Services CostOfRatableProductAndRelatedSupportAndServices	166000
CY2012Q2	infn	Other Comprehensive Income Loss Reclassification Adjustment For Available For Sale Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAvailableForSaleSecuritiesIncludedInNetIncomeNetOfTax	-283000
CY2013Q1	infn	Realized Gains On Calls RealizedGainsOnCalls	200000
CY2013Q1	infn	Exercise Of Warrants Value ExerciseOfWarrantsValue	500000
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	116911000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.09
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	116911000	shares
CY2013Q2	us-gaap	Revenues Revenues	138385000
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10910000
CY2013Q2	us-gaap	Gross Profit GrossProfit	51654000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9408000
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	120153000
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-158000
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	207000
CY2013Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-700000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-99000
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8608000
CY2013Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	17738000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-802000
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-800000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-10009000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-901000
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11426000
CY2013Q2	us-gaap	Cost Of Services CostOfServices	6533000
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	80129000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17155000
CY2013Q2	us-gaap	Interest Expense InterestExpense	849000
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	86731000
CY2013Q2	us-gaap	Product Warranty Expense ProductWarrantyExpense	6178000
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31681000
CY2013Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	50000
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8184000
CY2013Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	849000
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	60262000
CY2013Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	580000
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	601000
CY2013Q2	infn	Provision For Income Taxes Percentage ProvisionForIncomeTaxesPercentage	0.064	pure
CY2013Q2	infn	Product Warranty Utilization ProductWarrantyUtilization	2055000
CY2013Q2	infn	Ratable Product And Related Support And Services RatableProductAndRelatedSupportAndServices	494000
CY2013Q2	infn	Allocated Share Based Compensation Expense Before Amortization Of Prior Periods Deferred Inventory Cost AllocatedShareBasedCompensationExpenseBeforeAmortizationOfPriorPeriodsDeferredInventoryCost	6494000
CY2013Q2	infn	Product Warranty Change In Estimate ProductWarrantyChangeInEstimate	-1094000
CY2013Q2	infn	Contractual Interest Expense ContractualInterestExpense	219000
CY2013Q2	infn	Amortization Of Deferred Inventory Cost Recognized As Share Based Compensation Expense AmortizationOfDeferredInventoryCostRecognizedAsShareBasedCompensationExpense	1690000
CY2013Q2	infn	Cost Of Ratable Product And Related Support And Services CostOfRatableProductAndRelatedSupportAndServices	69000
CY2013Q2	infn	Euro Denominated Receivables And Typically Maturities EuroDenominatedReceivablesAndTypicallyMaturities	no more than 30 days
CY2013Q2	infn	Number Of Shares Available For Grant Cost NumberOfSharesAvailableForGrantCost	2500000	shares
CY2013Q2	infn	Other Comprehensive Income Loss Reclassification Adjustment For Available For Sale Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAvailableForSaleSecuritiesIncludedInNetIncomeNetOfTax	0

Files In Submission

Name	View Source	Status
0001193125-13-318863-index-headers.html	Edgar Link	pending
0001193125-13-318863-index.html	Edgar Link	pending
0001193125-13-318863.txt	Edgar Link	pending
0001193125-13-318863-xbrl.zip	Edgar Link	pending
d553658d10q.htm	Edgar Link	pending
d553658dex311.htm	Edgar Link	pending
d553658dex312.htm	Edgar Link	pending
d553658dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
infn-20130629.xml	Edgar Link	completed
infn-20130629.xsd	Edgar Link	pending
infn-20130629_cal.xml	Edgar Link	unprocessable
infn-20130629_def.xml	Edgar Link	unprocessable
infn-20130629_lab.xml	Edgar Link	unprocessable
infn-20130629_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R57.htm	Edgar Link	pending
R57.xml	Edgar Link	unprocessable
R58.htm	Edgar Link	pending
R58.xml	Edgar Link	unprocessable
R59.htm	Edgar Link	pending
R59.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R60.htm	Edgar Link	pending
R60.xml	Edgar Link	unprocessable
R61.htm	Edgar Link	pending
R61.xml	Edgar Link	unprocessable
R62.htm	Edgar Link	pending
R62.xml	Edgar Link	unprocessable
R63.htm	Edgar Link	pending
R63.xml	Edgar Link	unprocessable
R64.htm	Edgar Link	pending
R64.xml	Edgar Link	unprocessable
R65.htm	Edgar Link	pending
R65.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INFN
Infinera Corp Stock $infn

2013 Q2 Form 10-Q Financial Statement

#000119312513318863 Filed on August 05, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFN Infinera Corp Stock $infn

2013 Q2 Form 10-Q Financial Statement

#000119312513318863 Filed on August 05, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFN
Infinera Corp Stock $infn